A lawsuit was filed on behalf of investors in Ampio Pharmaceuticals, Inc. (NYSE: AMPE) shares over alleged securities laws violations.

San Diego, CA -- (SBWire) -- 09/04/2018 --An investor, who purchased shares of Ampio Pharmaceuticals, Inc. (NYSE: AMPE), filed a lawsuit over alleged violations of Federal Securities Laws by Ampio Pharmaceuticals.

Investors who purchased shares of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint the plaintiff alleges on behalf of purchasers of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) common shares between December 14, 2017 and August 7, 2018, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between December 14, 2017 and August 7, 2018, the Defendants made false and/or misleading statements and/or failed to disclose that the FDA would find Ampio's AP-003-C Phase 3 clinical trial inadequate and not well-controlled, that as a result, Ampio had not successfully completed two pivotal clinical trials for Ampion, and that consequently, Defendants' public statements were materially false and misleading at all relevant times.

Those who purchased shares of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.